Sichenzia Ross Ference Carmel LLP Represents Beyond Air, Inc. in a $20.6 Million Private Placement Offering

Press Release – New York, NY – September 27, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients, in a $20.6 million private placement offering.  Under the terms of the securities purchase agreement, the investors have agreed to purchase shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase shares of common stock, at a purchase price of $0.51 per common share (or $0.5099 per pre-funded warrant in lieu thereof) and accompanying warrant in a private placement priced at-the-market under the rules of the Nasdaq Stock Market.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Rohini Sud.